Portola Pharmaceuticals Inc. buy marge
Start price
01.01.19
/
50%
€16.69
Target price
06.07.20
€19.00
Performance (%)
-4.09%
End price
06.07.20
-
Summary
This prediction ended on 06.07.20 with a price of -. With a performance of -4.09%, the BUY prediction by marge finished with a loss. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
iShares Core DAX® | 1.395% | -0.696% | 15.472% | 15.907% |
iShares Nasdaq 100 | 2.287% | 7.501% | 34.748% | 53.474% |
iShares Nikkei 225® | 1.617% | 2.769% | 11.442% | 8.194% |
iShares S&P 500 | 0.659% | 4.280% | 26.778% | 45.322% |
Comments by marge for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
marge stimmt der Buy-Einschätzung von stratec zu
marge stimmt am 01.01.2019 der Buy-Einschätzung von stratec mit dem Kursziel 38$ zu.
Überschrift: Portola's two approved drugs are targeting significant markets:
Kursziel geändert auf 12,0
Kursziel geändert auf 19,0
Stopped prediction by marge for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€49.88
28.06.17
28.06.17
€54.12
20.12.18
20.12.18
-70.04%
20.12.18
20.12.18
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€48.25
23.07.15
23.07.15
€54.12
18.07.16
18.07.16
-57.92%
18.07.16
18.07.16
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.41
21.06.15
21.06.15
€45.00
22.07.15
22.07.15
18.34%
22.07.15
22.07.15